Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Atara Biotherapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 35 | −12 |
| Shares | 2.84M | 61.1K | 2.41M | −360.4K (−13.0%) |
| Value | $24.1M | $519.7K | $19.6M | −$3.92M (−16.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 60,954 | $495.6K | 0.00% |
| Global Retirement Partners, LLC | 750 | $6.10K | 0.00% |
| Advisor Group Holdings, Inc. | 644 | $5.24K | 0.00% |
| GAMMA Investing LLC | 56 | $455 | 0.00% |
Sold out (16)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Boxer Capital, LLC | 166,000 | $1.41M |
| Qube Research & Technologies Ltd | 102,663 | $872.6K |
| Woodline Partners LP | 70,889 | $602.6K |
| Prudential Financial Inc | 36,340 | $308.9K |
| Northern Trust Corp | 31,492 | $267.7K |
| Charles Schwab Investment Management Inc | 26,155 | $222.3K |
| AQR Capital Management LLC | 15,079 | $128.2K |
| Susquehanna International Group, LLP | 14,455 | $122.9K |
| Lake Street Advisors Group, LLC | 11,000 | $93.5K |
| Cubist Systematic Strategies, LLC | 9,271 | $78.8K |
| Point72 Asia (Singapore) Pte. Ltd. | 6,292 | $53.5K |
| Mirae Asset Global ETFs Holdings Ltd. | 1,927 | $16.4K |
| CWM, LLC | 542 | $5.00K |
| Macquarie Group Ltd | 197 | $1.68K |
| Federated Hermes, Inc. | 57 | $485 |
| New York State Common Retirement Fund | 32 | $272 |
Not filed for Q3 2024 yet (1)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 61,145 | $519.7K |